In this Series paper, we review the current evidence for the use of high-flow oxygen therapy,
inhaled gases, and aerosols in the care of critically ill patients. The available evidence …

Background Whether noninvasive ventilation should be administered in patients with acute
hypoxemic respiratory failure is debated. Therapy with high-flow oxygen through a nasal …

Acute hypoxemic respiratory failure (AHRF) is a common reason for admission to Intensive
Care Units (ICUs) and may be caused by a number of underlying processes including, but …

BACKGROUND: Beneficial effects of high-flow nasal cannula (HFNC) oxygen on
oxygenation and respiratory parameters have been reported in a small number of subjects …

BACKGROUND: Humidified high flow nasal cannula oxygen therapy is increasingly
available in Australian adult intensive care units. Its use in paediatric populations has been …

Acute respiratory failure (ARF) represents one of the most common causes of intensive care
unit admission and oxygen therapy remains the first-line therapy in the management of …

High-flow nasal oxygen (HFNO) delivers heated, humidified oxygen at very high flow rates
(20-70 L/min) at concentrations up to 100% through a specialized nasal cannula. HFNO has …

The mortality for acute respiratory distress syndrome (ARDS) remains unacceptably high,
between 40% and 50%. 1, 2 The syndrome is characterized by hypoxemia secondary to …

Incremental gains in understanding the influence of various factors on aerosol delivery in
concert with technological advancements over the past 2 decades have fueled an ever …

Background Although non-invasive ventilation (NIV) is recommended for
immunocompromised patients with acute respiratory failure in the intensive care unit (ICU), it …